Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-04

Clinical Trial Update: Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchronization Patients With Quadripolar Left Ventricular Leads

View source ↗

Summary

A completed clinical trial evaluated pacing strategies to avoid phrenic nerve stimulation in heart failure patients receiving cardiac resynchronization therapy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quadripolar left ventricular lead for cardiac resynchronization therapy

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Status: COMPLETED